中国防痨杂志 ›› 2021, Vol. 43 ›› Issue (3): 291-294.doi: 10.3969/j.issn.1000-6621.2021.03.017
收稿日期:
2020-12-07
出版日期:
2021-03-10
发布日期:
2021-03-03
通信作者:
徐贵生
E-mail:guishengxu123@163.com
基金资助:
ZHANG Chun-xia, XU Gui-sheng(), SHI Jin-yan
Received:
2020-12-07
Online:
2021-03-10
Published:
2021-03-03
Contact:
XU Gui-sheng
E-mail:guishengxu123@163.com
摘要:
耐多药结核病的防治对于结核病的防控具有重要意义,已成为结核病防治的难点和热点问题。早期对结核病患者进行耐多药检测能够提高耐多药结核病患者的治疗成功率。耐多药结核病的诊断方法包括传统的培养方法及新型分子生物学诊断方法。作者对耐多药结核病的诊断方法进行综述,以期为耐多药结核病防治提供科学依据。
张春霞, 徐贵生, 时金艳. 耐多药结核病诊断方法研究进展[J]. 中国防痨杂志, 2021, 43(3): 291-294. doi: 10.3969/j.issn.1000-6621.2021.03.017
ZHANG Chun-xia, XU Gui-sheng, SHI Jin-yan. Research progress on diagnostic methods of multidrug-resistant tuberculosis[J]. Chinese Journal of Antituberculosis, 2021, 43(3): 291-294. doi: 10.3969/j.issn.1000-6621.2021.03.017
[1] | 杨松, 严晓峰. 贝达喹啉治疗耐多药与广泛耐药结核病的现状和展望. 结核病与肺部健康杂志, 2019,8(4):249-252. doi: 10.3969/j.issn.2095-3755.2019.04.004. |
[2] | World Health Organization. Global tuberculosis report 2020. Geneva: World Health Organization, 2020. |
[3] | 刘一典, 桂徐蔚, 申晓娜, 等. 2019年《ATS/CDC/ERS/IDSA临床实践指南:耐药结核病治疗》解读及与我国《耐药结核病化学治疗指南(2019年)》对比. 中国防痨杂志, 2020,42(1):12-16. doi: 10.3969/j.issn.1000-6621.2020.01.005. |
[4] |
Bolhuis MS, van der Werf TS, Akkerman OW. Treatment of Highly Drug-Resistant Pulmonary Tuberculosis. N Engl J Med, 2020,382(24):2376-2377. doi: 10.1056/NEJMc2009939.
doi: 10.1056/NEJMc2009939 URL pmid: 32521141 |
[5] | 中国防痨协会. 耐药结核病化学治疗指南(2019年简版). 中国防痨杂志, 2019,41(10):1025-1073. doi: 10.3969/j.issn.1000-6621.2019.10.001. |
[6] | 朱庆义. 结核分枝杆菌耐多药基因及其检测新技术. 中华临床实验室管理电子杂志, 2020,8(2):65-70. doi: 10.3877/cma.j.issn.2095-5820.2020.02.001. |
[7] |
Lange C, Chesov D, Heyckendorf J, et al. Drug-resistant tuberculosis: An update on disease burden, diagnosis and treatment. Respirology, 2018,23(7):656-673. doi: 10.1111/resp.13304.
doi: 10.1111/resp.13304 URL pmid: 29641838 |
[8] |
Schön T, Miotto P, Köser CU, et al. Mycobacterium tuberculosis drug-resistance testing: challenges, recent developments and perspectives. Clin Microbiol Infect, 2017,23(3):154-160. doi: 10.1016/j.cmi.2016.10.022.
doi: 10.1016/j.cmi.2016.10.022 URL pmid: 27810467 |
[9] | World Health Organization. Guidelines for surveillance of drug resistance in tuberculosis. 4th ed. Geneva: World Health Organization, 2009. |
[10] |
Rancoita PMV, Cugnata F, Gibertoni Cruz AL, et al. Validating a 14-Drug Microtiter Plate Containing Bedaquiline and Delamanid for Large-Scale Research Susceptibility Testing of Mycobacterium tuberculosis. Antimicrob Agents Chemother, 2018,62(9):e00344-18. doi: 10.1128/AAC.00344-18.
doi: 10.1128/AAC.00344-18 URL pmid: 29941636 |
[11] | 李辉. 液体培养方法在结核病和耐药结核病诊断中的应用. 中华检验医学杂志, 2014,37(8):637-638. doi: 10.3760/cma.j.issn.1009-9158.2014.08.019. |
[12] |
Sivaramakrishnan G, Subramanyam B, Kumar MP, et al. Validation of bedaquiline drug-susceptibility testing by BACTEC MGIT 960 system for Mycobacterium tuberculosis. Int J Mycobacteriol, 2019,8(4):329-332. doi: 10.4103/ijmy.ijmy_151_19.
doi: 10.4103/ijmy.ijmy_151_19 URL pmid: 31793501 |
[13] |
Opota O, Mazza-Stalder J, Greub G, et al. The rapid molecular test Xpert MTB/RIF ultra: towards improved tuberculosis diagnosis and rifampicin resistance detection. Clin Microbiol Infect, 2019,25(11):1370-1376. doi: 10.1016/j.cmi.2019.03.021.
doi: 10.1016/j.cmi.2019.03.021 URL pmid: 30928564 |
[14] | World Health Organization. Molecular line probe assays for rapid screening of patients at risk of multidrug-resistant tuberculosis (MDR-TB). Geneva: World Health Organization, 2008. |
[15] | World Health Organization. The use of molecular line probe assays for the detection of resistance to isoniazid and rifampicin. Geneva: World Health Organization, 2016. |
[16] | World Health Organization. WHO consolidated guidelines on tuberculosis. Module 3: diagnosis—rapid diagnostics for tuberculosis detection. Geneva: World Health Organization, 2020. |
[17] | Lee JH, Jo KW, Shim TS. Correlation between GenoType MTBDRplus Assay and Phenotypic Susceptibility Test for Prothionamide in Patients with Genotypic Isoniazid Resistance. Tuberc Respir Dis (Seoul), 2019,82(2):143-150. doi: 10.4046/trd.2018.0027. |
[18] |
Siddiqui S, Brooks MB, Malik AA, et al. Evaluation of GenoType MTBDRplus for the detection of drug-resistant Mycobacterium tuberculosis on isolates from Karachi, Pakistan. PLoS One, 2019,14(8):e0221485. doi: 10.1371/journal.pone.0221485.
doi: 10.1371/journal.pone.0221485 URL pmid: 31425565 |
[19] |
Rufai SB, Umay K, Singh PK, et al. Performance of Genotype MTBDRsl V2.0 over the Genotype MTBDRsl V1 for detection of second line drug resistance: An Indian perspective. PLoS One, 2020,15(3):e0229419. doi: 10.1371/journal.pone.0229419.
URL pmid: 32130233 |
[20] |
Yasemin A, Ahmad S, Afzal S, et al. Evaluation of GeneXpert MTB/RIF Assay for Detection of Pulmonary Tuberculosis on Sputum Samples. J Coll Physicians Surg Pak, 2019,29(1):66-69. doi: 10.29271/jcpsp.2019.01.66.
doi: 10.29271/jcpsp.2019.01.66 URL pmid: 30630573 |
[21] |
Shao L, Qiu C, Zheng L, et al. Comparison of diagnostic accuracy of the GeneXpert Ultra and cell-free nucleic acid assay for tuberculous meningitis: A multicentre prospective study. Int J Infect Dis, 2020,98:441-446. doi: 10.1016/j.ijid.2020.06.076.
URL pmid: 32599283 |
[22] |
Ali IF, Babak F, Fazlollah MS, et al. Rapid detection of MDR-Mycobacterium tuberculosis using modified PCR-SSCP from clinical Specimens. Asian Pac J Trop Biomed, 2014,4(Suppl 1):S165-170. doi: 10.12980/APJTB.4.2014C1186.
doi: 10.12980/APJTB.4.2014C1186 URL pmid: 25183075 |
[23] |
Choi W, Lee J, Cho E, et al. Accurate and effective multidrug-resistant Mycobacterium tuberculosis detection method using gap-filling ligation coupled with high-resolution capillary electrophoresis-based single strand conformation polymorphism. Sci Rep, 2017,7:46090. doi: 10.1038/srep46090.
doi: 10.1038/srep46090 URL pmid: 28422112 |
[24] |
Tahmasebi P, Farnia P, Sheikholslami F, et al. Rapid identification of extensively and extremely drug resistant tuberculosis from multidrug resistant strains; using PCR-RFLP and PCR-SSCP. Iran J Microbiol, 2012,4(4):165-170.
URL pmid: 23205246 |
[25] | 李栋梁, 侯瑞生, 王侃, 等. PCR-SSCP法检测结核分枝杆菌耐药基因突变分析. 中国卫生检验杂志, 2014,24(21):3127-3128. |
[26] |
Coll F, McNerney R, Preston MD, et al. Rapid determination of anti-tuberculosis drug resistance from whole-genome sequences. Genome Med, 2015,7(1):51. doi: 10.1186/s13073-015-0164-0.
doi: 10.1186/s13073-015-0164-0 URL pmid: 26019726 |
[27] | Doyle RM, Burgess C, Williams R, et al. Direct Whole-Genome Sequencing of Sputum Accurately Identifies Drug-Resistant Mycobacterium tuberculosis Faster than MGIT Culture Sequencing. J Clin Microbiol, 2018,56(8):e00666-18. doi: 10.1128/JCM.00666-18. |
[28] |
Cole ST, Brosch R, Parkhill J, et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature, 1998,393(6685):537-544. doi: 10.1038/31159.
doi: 10.1038/31159 URL pmid: 9634230 |
[29] |
Roa MB, Tablizo FA, Morado EKD, et al. Whole-genome sequencing and single nucleotide polymorphisms in multidrug-resistant clinical isolates of Mycobacterium tuberculosis from the Philippines. J Glob Antimicrob Resist, 2018,15:239-245. doi: 10.1016/j.jgar.2018.08.009.
doi: 10.1016/j.jgar.2018.08.009 URL pmid: 30130640 |
[30] |
Gröschel MI, Walker TM, van der Werf TS, et al. Pathogen-based precision medicine for drug-resistant tuberculosis. PLoS Pathog, 2018,14(10):e1007297. doi: 10.1371/journal.ppat.1007297.
doi: 10.1371/journal.ppat.1007297 URL pmid: 30335850 |
[31] |
Makhado NA, Matabane E, Faccin M, et al. Outbreak of multidrug-resistant tuberculosis in South Africa undetected by WHO-endorsed commercial tests: an observational study. Lancet Infect Dis, 2018,18(12):1350-1359. doi: 10.1016/S1473-3099(18)30496-1.
doi: 10.1016/S1473-3099(18)30496-1 URL pmid: 30342828 |
[32] |
Tagliani E, Hassan MO, Waberi Y, et al. Culture and Next-generation sequencing-based drug susceptibility testing unveil high levels of drug-resistant-TB in Djibouti: results from the first national survey. Sci Rep, 2017,7(1):17672. doi: 10.1038/s41598-017-17705-3.
doi: 10.1038/s41598-017-17705-3 URL pmid: 29247181 |
[33] |
Colman RE, Mace A, Seifert M, et al. Whole-genome and targeted sequencing of drug-resistant Mycobacterium tuberculosis on the iSeq100 and MiSeq: A performance, ease-of-use, and cost evaluation. PLoS Med, 2019,16(4):e1002794. doi: 10.1371/journal.pmed.1002794.
doi: 10.1371/journal.pmed.1002794 URL pmid: 31039166 |
[34] |
Tyler AD, Christianson S, Knox NC, et al. Comparison of Sample Preparation Methods Used for the Next-Generation Sequencing of Mycobacterium tuberculosis. PLoS One, 2016,11(2):e0148676. doi: 10.1371/journal.pone.0148676.
doi: 10.1371/journal.pone.0148676 URL pmid: 26849565 |
[35] |
Daniyarov A, Molkenov A, Rakhimova S, et al. Whole genome sequence data of Mycobacterium tuberculosis XDR strain, isolated from patient in Kazakhstan. Data Brief, 2020,33:106416. doi: 10.1016/j.dib.2020.106416.
doi: 10.1016/j.dib.2020.106416 URL pmid: 33102665 |
[36] | Rosse IC, Assis JG, Oliveira FS, et al. Whole genome sequencing of Guzerá cattle reveals genetic variants in candidate genes for production, disease resistance, and heat tolerance. Mamm Genome, 2017,28(1/2):66-80. doi: 10.1007/s00335-016-9670-7. |
[37] |
Ko DH, Lee EJ, Lee SK, et al. Application of next-generation sequencing to detect variants of drug-resistant Mycobacterium tuberculosis: genotype-phenotype correlation. Ann Clin Microbiol Antimicrob, 2019,18(1):2. doi: 10.1186/s12941-018-0300-y.
doi: 10.1186/s12941-018-0300-y URL pmid: 30606210 |
[1] | 梁瑞云, 方伟军, 任会丽, 黎惠如, 张晖, 李城城. 耐药肺结核伴空洞患者的CT表现特征分析[J]. 中国防痨杂志, 2021, 43(4): 341-345. |
[2] | 林静, 张晨, 董宇杰, 刘子臣, 李琨, 车南颖. HIV感染/AIDS患者感染性浅表淋巴结病的临床病理特征分析[J]. 中国防痨杂志, 2021, 43(3): 268-273. |
[3] | 崔晓敬, 魏栋, 王春雷, 曹彬. 分子生物学和液体培养方法提高综合医院结核病病原学诊断能力的价值[J]. 中国防痨杂志, 2021, 43(2): 143-146. |
[4] | 米洁, 薛勇, 白雪娟, 吴雪琼. 淋巴细胞亚群检测在结核病诊疗中的应用进展[J]. 中国防痨杂志, 2021, 43(2): 178-185. |
[5] | 李潜, 汪林宝, 罗佩嘉, 韦林, 刘玉钢, 任磊鹏, 丁超. 两种技术对结核性脓胸不同手术标本病原学及耐药性检测结果分析[J]. 中国防痨杂志, 2021, 43(1): 52-57. |
[6] | 张开义, 吕正煊, 刘永莉, 张乐, 朱江春, 喻明丽. 脓肿分枝杆菌致患者多系统播散性感染一例的诊治过程分析[J]. 中国防痨杂志, 2021, 43(1): 66-71. |
[7] | 刘健雄, 杜雨华, 沈鸿程, 张广川, 吴桂锋, 赖铿, 雷宇, 李铁钢. 2008—2018年广州市结核病患者诊断延误影响因素分析[J]. 中国防痨杂志, 2021, 43(1): 80-86. |
[8] | 李果, 庞先琼, 徐华, 敬明燕, 范庞双, 陈绍平. 潜伏性结核感染诊治进展[J]. 中国防痨杂志, 2021, 43(1): 91-95. |
[9] | 周林, 刘二勇, 孟庆琳, 陈明亭, 周新华, 高微微, 林明贵, 谢汝明. 《WS 288—2017 肺结核诊断》标准实施后肺结核诊断质量评估分析[J]. 中国防痨杂志, 2020, 42(9): 910-915. |
[10] | 刘二勇, 王前, 周林, 张国钦, 张修磊, 马永成, 杨枢敏, 王毳, 孟庆琳, 陈明亭, 林明贵, 屠德华. 我国部分地区病原学检测阴性肺结核诊断质量现状分析[J]. 中国防痨杂志, 2020, 42(9): 916-920. |
[11] | 王前, 周林, 刘二勇, 赵雁林, 李涛, 陈明亭, 杨丽佳, 王嘉. 我国县级结核病定点医疗机构结核病诊断能力现况调查研究[J]. 中国防痨杂志, 2020, 42(9): 926-930. |
[12] | 梁瑞云, 方伟军, 任会丽, 黎惠如, 张晖. 非结核分枝杆菌肺病并发与未并发糖尿病患者的CT征象研究[J]. 中国防痨杂志, 2020, 42(9): 962-967. |
[13] | 南海, 张芸, 杨新婷, 段鸿飞. GeneXpert MTB/RIF对骨关节结核诊断价值的Meta分析[J]. 中国防痨杂志, 2020, 42(9): 973-980. |
[14] | 陈玉妹, 罗兴雄, 陈成江, 苏萍, 王春雷. 海南省地市及县级结核病定点医院服务能力分析[J]. 中国防痨杂志, 2020, 42(9): 992-993. |
[15] | 中国防痨协会 中国防痨协会学校与儿童结核病防治专业分会 《中国防痨杂志》编辑委员会. 重组结核杆菌融合蛋白(EC)临床应用专家共识[J]. 中国防痨杂志, 2020, 42(8): 761-768. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||